This is an external website. ITN is not responsible for any content on the third party website.
IBA signs contract with Yale New Haven Health and Hartford HealthCare ...
May 21, 2024 — IBA, a world leader in particle accelerator technology, announced that it has signed a contract with the ...
IBA Acquires Radcal Corporation to Expand Medical Imaging Quality ...
February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...
iThemba LABS ready to start production of Strontium-82 and Germanium ...
January 23, 2024 — IBA, a world leader in particle accelerator technology and the world’s leading provider of ...
IBA Pioneers Theranostic Advancements, Empowering the Market to ...
December 12, 2023 — IBA, a world leader in particle accelerator technology and of radiopharmaceutical production ...
IBA Plans Total System Restoration on its First-ever Proton Therapy ...
October 23, 2023 — IBA, a world leader in particle accelerator technology and the world’s leading provider of proton ...
PET Radiotracer Market anticipated to reach $3.2 Billion in Revenues ...
According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...
IBA Signs Contract with Partner CGN Medical Technology for the ...
August 15, 2023 — IBA, a world leader in particle accelerator technology and the world’s leading provider of proton ...
IBA Wins 10 Proton Therapy System Contract in Spain
January 2, 2023 — IBA, a world leader in particle accelerator technology, today confirms that it has signed a contract ...
ElsMed, Novatec and IBA Sign Contract to Install Radiopharmaceutical ...
October 6, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...
The PROTECT-Trial Consortium Enrolls First Patient into Proton Therapy ...
September 2, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology ...